US 12,097,189
Application 18/613,281 · Granted Sep 24, 2024
Pharmaceutical composition for modified release
Estimated expiration
September 28, 2029
2y 312d remaining
- Application 18437323 has not been granted a patent number
Earliest effective filing
Mar 28, 2011
+ 20 years
Mar 28, 2031
PTA +0d
Mar 28, 2031
TD cap (US 10,842,780)
Sep 28, 2029
Final
Sep 28, 2029
- Earliest effective filing
- Mar 28, 2011
- + 20 years
- Mar 28, 2031
- PTA +0d
- Mar 28, 2031
- TD cap (US 10,842,780)
- Sep 28, 2029
- Final
- Sep 28, 2029
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).
Calculation details
Base term
- Filing date
- March 22, 2024
- Earliest effective filing
- March 28, 2011
- Issue date
- September 24, 2024
- PTA
- 0 days
- Base expiry (before PTA)
- March 28, 2031
March 28, 2011 + 20 years = March 28, 2031
- Continuation of application 18/437,323, filed Feb 9, 2024
- Continuation of application 18/339,513, filed Jun 22, 2023
- Continuation of application 17/114,890, filed Dec 8, 2020, issued as US 11,707,451
- Continuation of application 14/584,933, filed Dec 29, 2014
- Divisional of application 13/073,721, filed Mar 28, 2011
- Divisional of application 13/073,721, filed Mar 28, 2011
- Continuation of application 14/584,933, filed Dec 29, 2014
- Divisional of application 13/073,721, filed Mar 28, 2011
- Continuation of application 17/114,890, filed Dec 8, 2020, issued as US 11,707,451
- Continuation of application 14/584,933, filed Dec 29, 2014
- Divisional of application 13/073,721, filed Mar 28, 2011
- Continuation of application 18/339,513
- Continuation of application 17/114,890, filed Dec 8, 2020, issued as US 11,707,451
- Continuation of application 14/584,933, filed Dec 29, 2014
- Divisional of application 13/073,721, filed Mar 28, 2011
- PRO61/318,569 — Provisional — not used for base term
- PRO61/318,569 — Provisional — not used for base term
- PRO61/318,569 — Provisional — not used for base term
- PRO61/318,569 — Provisional — not used for base term
- PRO61/318,569 — Provisional — not used for base term
- PRO61/318,569 — Provisional — not used for base term
Terminal disclaimers
TD caps expiration to September 28, 2029 (earliest expiring referenced patent: US 10,842,780)
US 11,707,451· Application 17/114,890Capping patent
Pharmaceutical composition for modified release
- Filing date
- Dec 8, 2020
- Earliest effective filing
- Mar 28, 2011
- Issue date
- Jul 25, 2023
- PTA
- +44 days
- Calculated expiration
- May 11, 2031
Continuation of 14/584,933, filed Dec 29, 2014
Divisional of 13/073,721, filed Mar 28, 2011
Divisional of 13/073,721, filed Mar 28, 2011
Mar 28, 2011 + 20y + 44d PTA = May 11, 2031
US 10,842,780· Application 15/432,854Capping patent
Pharmaceutical composition for modified release
- Filing date
- Feb 14, 2017
- Earliest effective filing
- Sep 28, 2009
- Issue date
- Nov 24, 2020
- PTA
- 0 days
- Calculated expiration
- Sep 28, 2029
Continuation of 12/568,313, filed Sep 28, 2009
Sep 28, 2009 + 20y = Sep 28, 2029
US 8,877,214· Application 13/073,677
Pharmaceutical composition for modified release
- Filing date
- Mar 28, 2011
- Earliest effective filing
- Mar 28, 2011
- Issue date
- Nov 4, 2014
- PTA
- +43 days
- Calculated expiration
- May 10, 2031
Mar 28, 2011 + 20y + 43d PTA = May 10, 2031
US 12,059,409· Application 18/613,270(from application 18/613,270)
Pharmaceutical composition for modified release
- Filing date
- Mar 22, 2024
- Earliest effective filing
- Sep 28, 2009
- Issue date
- Aug 13, 2024
- PTA
- 0 days
- Calculated expiration
- Sep 28, 2029
Continuation of 18/448,244, filed Aug 11, 2023
Continuation of 16/952,795, filed Nov 19, 2020
Divisional of 15/432,854, filed Feb 14, 2017, issued as US 10,842,780
Continuation of 12/568,313, filed Sep 28, 2009
Continuation of 12/568,313, filed Sep 28, 2009
Divisional of 15/432,854, filed Feb 14, 2017, issued as US 10,842,780
Continuation of 12/568,313, filed Sep 28, 2009
Continuation of 16/952,795, filed Nov 19, 2020
Divisional of 15/432,854, filed Feb 14, 2017, issued as US 10,842,780
Continuation of 12/568,313, filed Sep 28, 2009
Sep 28, 2009 + 20y = Sep 28, 2029
US APP:18437323(from application 18/437,323)
Could not resolve calculation details
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
You have the date. Your AI can have the file.
Application 18/613,281 · US 12,097,189
PatentReply compiles the prosecution history behind US 12,097,189: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new published application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12097189Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.